Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
about
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosisPersistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-IBone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice.Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.Generation of retroviruses for the overexpression of cytosolic and mitochondrial glutathione reductase in macrophages in vivoLentiviral transduction of apoAI into hematopoietic progenitor cells and macrophages: applications to cell therapy of atherosclerosis.A macrophage-specific synthetic promoter for therapeutic application of adiponectin.HDL-mediated mechanisms of protection in cardiovascular disease.Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosisImpaired secretion of apolipoprotein E2 from macrophages.Expression of caveolin-1 enhances cholesterol efflux in hepatic cells.Adeno-associated virus serotype 2 mediated transduction and coexpression of the human apoAI and SR-BI gene in HepG2 cells.Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis.Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits.Expression and secretion of human apolipoprotein A-I in the heart.Human Apolipoprotein E concentration in response to diseases and therapeutic treatments
P2860
Q26782972-5C8EB4F3-D30E-4AC1-AB1C-C915D2A5C30EQ28585282-25764C27-190E-471A-9CF0-74655CFDD0A5Q33982567-9510340E-1D85-42B1-8EDE-F699B3C70217Q34299310-97B135D0-DB0C-4191-9210-A8EEE9D17CE5Q35120931-334D931B-C314-4C04-B23B-09122F2D6190Q36495659-FF0CEF69-0D36-439A-85A8-4F06CDAB9558Q37348110-3FF0AEEB-C01D-4A33-A127-E1313453BC3AQ37684885-611B9811-35DF-47FE-B584-4B2446720BA2Q38220762-78D7AB3F-1802-4188-A628-71F802FCAFFBQ38296207-CA2D31D9-DA91-4ACA-ADF4-536715B56514Q38647828-E0348F12-633C-45CC-9E02-9FF891346260Q40162654-550ADE1E-4B54-4516-AB97-962DDA3DA8F8Q40598222-54F69DA7-EEFB-4C58-8C37-DE75BD316E59Q43496795-837AEA1D-EFC2-4B12-ABBC-EF48442893EDQ44177995-CB47AF1B-7D55-43CC-896C-9D71D9F543F0Q45862703-9ED84806-F620-40FD-9752-B8AF048F708BQ45874236-3C1E72BD-2246-412A-8FB6-6589C5707F32Q54732698-AD3B9C43-D41E-40AD-A781-162FA315D5DAQ57995824-98DD393A-B204-4A42-A1C5-B0DA39D007E6
P2860
Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@en
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@nl
type
label
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@en
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@nl
prefLabel
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@en
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@nl
P2093
P2860
P356
P1476
Retrovirus-mediated expression ...... ainst atherosclerosis in vivo.
@en
P2093
Ishiguro H
P2860
P304
36742-36748
P356
10.1074/JBC.M106027200
P407
P577
2001-07-26T00:00:00Z